MediPal Holdings Corporation (TYO:7459)

Japan flag Japan · Delayed Price · Currency is JPY
2,822.00
+40.50 (1.46%)
Apr 28, 2026, 3:30 PM JST
18.15%
Market Cap 577.66B
Revenue (ttm) 3.78T
Net Income (ttm) 41.46B
Shares Out 204.70M
EPS (ttm) 200.64
PE Ratio 14.07
Forward PE 14.90
Dividend 64.00 (2.30%)
Ex-Dividend Date Mar 30, 2026
Volume 575,000
Average Volume 333,790
Open 2,788.50
Previous Close 2,781.50
Day's Range 2,784.00 - 2,823.50
52-Week Range 2,222.50 - 3,070.00
Beta -0.01
RSI 44.32
Earnings Date May 13, 2026

About MediPal Holdings

Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprising medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is also involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; and animal health product... [Read more]

Sector Healthcare
Founded 1898
Employees 13,061
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 7459
Full Company Profile

Financial Performance

In fiscal year 2025, MediPal Holdings's revenue was 3.67 trillion, an increase of 3.16% compared to the previous year's 3.56 trillion. Earnings were 40.28 billion, a decrease of -2.88%.

Financial Statements

News

There is no news available yet.